ESCIN IIIA
UNII R5ASZ7K9VS

Substance Identification & Data

This profile provides standardized clinical and technical data for Escin Iiia, uniquely identified by the FDA Unique Ingredient Identifier (UNII) R5ASZ7K9VS.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 158800-84-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

R5ASZ7K9VS

CAS Registry Number

158800-84-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ESCIN IIIA

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C55H86O23

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

FYKKYSOHLJFKCW-LMYVUOPQSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

10057040

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@H]1([C@@H]([C@@H]([C@H]([C@@](O1)(O[C@@]2([C@H]([C@@]([C@H](O[C@]2(O[C@]3(CC[C@@]4([C@]5(CC=C6[C@@]7(CC([C@@H](OC(=O)/C(=C/C)/C)[C@H](OC(=O)C)[C@@]7([C@@H](C[C@]6([C@@]5(CC[C@]4(C3(C)C)[H])C)C)O)CO)(C)C)[H])[H])C)[H])[H])C(O)=O)(O[C@]8([C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)[H])[H])O)[H])[H])O)O)O)CO

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Escin Iiia. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

(3.BETA.,16.ALPHA.,21.BETA.,22.ALPHA.)-22-(ACETYLOXY)-16,28-DIHYDROXY-21-(((2E)-2-METHYL-1-OXO-2-BUTEN-1-YL)OXY)OLEAN-12-EN-3-YL O-.BETA.-D-GALACTOPYRANOSYL-(1->2)-O-(.BETA.-D-GLUCOPYRANOSYL-(1->4))-.BETA.-D-GLUCOPYRANOSIDURONIC ACID

.BETA.-D-GLUCOPYRANOSIDURONIC ACID, (3.BETA.,16.ALPHA.,21.BETA.(E),22.ALPHA.)-22-(ACETYLOXY)-16,28-DIHYDROXY-21-((2-METHYL-1-OXO-2-BUTENYL)OXY)OLEAN-12-EN-3-YL O-.BETA.-D-GALACTOPYRANOSYL-(1->2)-O-(.BETA.-D-GLUCOPYRANOSYL-(1->4))-

.BETA.-D-GLUCOPYRANOSIDURONIC ACID, (3.BETA.,16.ALPHA.,21.BETA.,22.ALPHA.)-22-(ACETYLOXY)-16,28-DIHYDROXY-21-(((2E)-2-METHYL-1-OXO-2-BUTEN-1-YL)OXY)OLEAN-12-EN-3-YL O-.BETA.-D-GALACTOPYRANOSYL-(1->2)-O-(.BETA.-D-GLUCOPYRANOSYL-(1->4))-

.BETA.-D-GLUCOPYRANOSIDURONIC ACID, (3.BETA.,16.ALPHA.,21.BETA.,22.ALPHA.)-22-(ACETYLOXY)-16,28-DIHYDROXY-21-(((2E)-2-METHYL-1-OXO-2-BUTENYL)OXY)OLEAN-12-EN-3-YL O-.BETA.-D-GALACTOPYRANOSYL-(1->2)-O-(.BETA.-D-GLUCOPYRANOSYL-(1->4))-

3.BETA.-(2-O-.BETA.-D-GALACTOPYRANOSYL-4-O-.BETA.-D-GLUCOPYRANOSYL-.BETA.-D-GLUCOPYRANURONOSYLOXY)OLEAN-12-ENE-16.ALPHA.,21.BETA.,22.ALPHA.,24,28-PENTOL 21-((E)-2-METHYL-2-BUTENOATE)22-ACETATE

ESCIN IIIA

Systematic Nomenclature

(2S,3S,4S,5R,6R)-6-(((3S,4AR,6AR,6BS,8R,8AR,9R,10R,12AS,14AR,14BR)-9-ACETOXY-8-HYDROXY-8A-(HYDROXYMETHYL)-4,4,6A,6B,11,11,14B-HEPTAMETHYL-10-(((E)-2-METHYLBUT-2-ENOYL)OXY)-1,2,3,4,4A,5,6,6A,6B,7,8,8A,9,10,11,12,12A,14,14A,14B-ICOSAHYDROPICEN-3-YL)OXY)-4-HYDROXY-5-(((2S,3R,4S,5R,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-2-YL)OXY)-3-(((2S,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-2-YL)OXY)TETRAHYDRO-2H-PYRAN-2-CARBOXYLIC ACID

SYS

External Clinical & Regulatory Resources

Previous UNIIR5A7J33U62

Next UNIIR5B19Q5RWZ